Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy
收藏Protein Data Bank Japan2024-10-16 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/5nx1
下载链接
链接失效反馈官方服务：
资源简介：
Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy Descriptor: Amyloid-beta A4 protein, Kallikrein-6 Authors: Shahar, A, Sananes, A, Radisky, E.S, Papo, N. Deposit date: 2017-05-09 Release date: 2018-05-30 Last modified: 2024-10-16 Method: X-RAY DIFFRACTION (1.853 Å) Cite: A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering. J.Biol.Chem., 293, 2018
创建时间：
2017-05-09
